|
|
|
| Our products |
|
|
 |
|
|
|
|
|
|
|
|
| Other information |
|
|
|
You are here : HOME > Research field > Oncology > Cell cycle > Cell cycle inhibitors
Cell cycle inhibitors
| Members of the Cip/Kip family of cyclin-dependent kinases inhibitors (CKIs) are well characterized for their role as negative regulators of G1-phase cell-cycle progression. >
Cip4,
Ras,
p21,
p27,
p57,
Kip1,
Kip2 | | Members of the Cip/Kip family of cyclin-dependent kinases inhibitors (CKIs) are well characterized for their role as negative regulators of G1-phase cell-cycle progression.
C9orf86,
CDKN2A,
p14ARF,
p16INK4a,
p19ARF,
CDKN2AIP,
ISOC2,
p15 INK4b,
p18 INK4c
| | The Rb protein is a tumor suppressor, which plays a pivotal role in the negative control of the cell cycle and in tumor progression.
KMT1A,
SUV39H1,
p105,
p107,
p130
| | p53 was the first tumour suppressor gene to be identified.
ALDH1L1,
BRCC45,
CDCA4,
CDKN2AIP,
DRAM,
GTSE1,
HAUSP,
USP7,
HOXA5,
JAB1,
MDM2,
OVCA1,
PARC,
PBK,
PRMT1,
Pirh2,
iASPP,
p53,
p63,
p73
| | Other cell cycle inhibitors.
ARHGAP20,
B7H4,
BAP1,
BIN1,
C8orf72,
CHFR,
CHMP1a,
CtBP1,
Cullin 1,
Cullin 2,
Cullin 3,
DBC1,
DBC2,
EB3,
ELAC2,
ENPP7,
ErbB 2,
FAT,
HRAS,
Hamartin,
JAK2,
Kisspeptin,
LKB1,
LYK5,
LZTS1,
MEI1,
MLL5,
MRG15,
MTBP,
NEK6,
Nck,
PHC3,
PTCH2,
RASSF4,
RSL1D1,
SCGB3A1,
SERTAD2,
TSG101,
TUSC2,
mTOR |
|